
TRAIL and its emerging receptors are the newest members of the zzso zzso zzso The zzso of TRAIL receptors by zzso binding leads to zzso through zzso zzso through an as yet unclear signaling zzso that does not require the zzso zzso The TRAIL zzso zzso is induced by DNA damage and appears to be regulated by the tumor zzso gene zzso Both the zzso zzso and zzso provide potential links between DNA zzso zzso of the zzso tumor zzso and zzso zzso While further evaluation of the role of TRAIL receptors in human cancer is zzso initial studies suggest that both zzso and zzso may be targets for zzso and that these zzso receptors may be tumor zzso zzso zzso the regulation of TRAIL and its receptors may thus be beneficial for the development of novel approaches for cancer zzso TRAIL appears to be a zzso zzso agent and thus offers promise as a novel therapy for cancer either through replacement of the zzso or potentially via gene zzso zzso studies suggest the potential to combine TRAIL with classical zzso zzso drugs to achieve synergistic cell zzso 

